•  
  •  
 

Content

About the Journal

The Mesopotamian Journal of Big Data (MJBD) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality, original research. We invite you to consult the journal's Aims & Scope for detailed information about its specific focus and peer-review policies.

As an open-access publication, MJBD ensures that your research is freely available online immediately upon publication. This means anyone can read, download, and share your work, maximizing its reach and impact.

Please note that this journal exclusively publishes manuscripts written in English.

The Mesopotamian Journal of Big Data accepts the following types of articles: original papers, short communications, review articles, editorial, and mini reviews.

Language

All manuscripts submitted to the Mesopotamian Journal of Big Data must be presented in clear, concise English. Authors who are not native English speakers, or who are not confident in their English writing skills, are strongly encouraged to seek professional assistance with manuscript preparation before submission. Reviewers are tasked with evaluating the scientific content, not with correcting grammatical errors. Deficiencies in language quality may detract from the scientific merit of the paper, potentially leading to delays in the acceptance process or outright rejection.

Types of Articles

The Mesopotamian Journal of Big Data actively seeks to publish four distinct categories of scholarly contributions: original articles, short communications, review articles, Editorial, and mini reviews.

  1. Original Articles: These are comprehensive research papers detailing in-depth investigations across various scientific disciplines relevant to Big Data.
  2. Short Communications: These submissions present research of significant importance, but their scope and length do not warrant a full-length paper. They should be complete manuscripts, with a maximum of 4 figures and tables combined, and a total word count not exceeding 3,000 words.
  3. Review Articles: Typically, these papers should be under 10,000 words, feature an unstructured abstract, and include an up-to-date bibliography. The journal also considers meta-analyses as review articles, with particular emphasis placed on their educational value.
  4. Mini Reviews: These are focused and concise reviews on important and recent topics within the journal's scope, with a word limit of 5,000 words.
  5. Editorial Papers: These typically offer perspectives, commentary, or critical insights from the editorial board or invited experts on topics relevant to the journal's scope.

Before Submission

Before submission, authors must ensure their manuscript adheres to the following criteria:

  1. The manuscript must be an original submission, not previously published or currently under review by another journal or conference.
  2. All research ethics guidelines must be met. A distinct "Ethics Approval" section is required if the study involves human subjects.
  3. The English used in the manuscript should be of an acceptable standard, free from grammatical errors and typos.
  4. Figures must be of good quality and uploaded as separate files.
  5. References should be correctly formatted and numbered sequentially as they appear in the text, with the specific reference style indicated.
  6. Only manuscripts demonstrating sufficient quality and aligning with the journal's aims and scope will proceed to review.
  7. Submissions must comply with the journal's guidelines provided below.
    Manuscripts that fail to meet these requirements will either be rejected or returned to the author prior to the peer review process.

Preparation of Manuscripts

Authors submitting to the Mesopotamian Journal of Big Data should prepare their manuscripts with meticulous attention to detail to ensure a smooth review and publication process.

Manuscripts should be submitted as Microsoft Word files through our online Manuscript Tracking System. For articles containing extensive mathematical content, LaTeX submissions are also accepted.

To minimize errors, authors are strongly advised to utilize the "spell-check" and "grammar-check" functions available in their word processing software. All text throughout the manuscript should have continuous line numbering, and every page must be clearly numbered.

Specific Elements

  • Equations: Please use an equation editor, such as MathType, for all mathematical expressions.
  • Tables: Tables should be constructed using the table function within your word processing software.
  • Headings: Employ a decimal system for headings, with no more than three levels (e.g., 1., 2., 2.1, 2.1.1).

Online Submission

Authors intending to publish with the Mesopotamian Journal of Big Data must submit their manuscripts through our online Manuscript Tracking System. Only submissions from one of the listed authors will be accepted, and the submitting author assumes full responsibility for the manuscript throughout the submission and peer review process. Our system currently supports Microsoft Word files exclusively, and there are no limitations on page count. Should technical difficulties prevent submission via the MTS, authors are encouraged to contact the journal's support team for assistance at support@mesopotamian.press.

Initial Evaluation

Upon submission, all manuscripts undergo an initial rigorous check by the Editorial Office of the Mesopotamian Journal of Big Data. This process verifies proper preparation and adherence to the journal's ethical policies. Every submitted manuscript is also screened for potential plagiarism using iThenticate software. Manuscripts that fail to meet the journal's ethical standards or overall quality criteria, or those that are incomplete or improperly formatted, will be rejected or returned to the authors before entering the formal peer review stage. After these preliminary checks, the Editorial Office will consult with the Editor-in-Chief to confirm if the manuscript aligns with MJBD's scope and possesses sufficient scientific merit. Manuscripts deemed to have insufficient priority for publication or containing significant language quality issues may be promptly rejected, with such decisions verified by the Editor-in-Chief.

Submission Declaration and Verification

By submitting an article to the Mesopotamian Journal of Big Data, authors implicitly declare that the work presented is original and has not been previously published, nor is it currently under consideration for publication elsewhere. This submission also signifies that all authors have read and approved the manuscript's content, and that its publication has been tacitly or explicitly authorized by the responsible authorities at the institution where the research was conducted. Furthermore, authors agree that, if accepted, the article will not be published elsewhere in its current form, whether in English or any other language, including electronic formats, without the express written consent of the copyright holder.

To ensure originality and uphold academic integrity, all manuscripts submitted to the Mesopotamian Journal of Big Data are rigorously screened for plagiarized content using Crossref Similarity Check Powered by iThenticate.

Article structure

The manuscript should be compiled in the following order:

  1. Title page
  2. Abstract, Keywords
  3. Introduction
  4. Material and methods (Experimental or Methodology or Patients and methods)
  5. Results
  6. Discussion (Results and discussion can be combined in one section)
  7. Conclusion
  8. Acknowledgment(s)
  9. Conflicts of Interest
  10. Funding
  11. Author contribution
  12. References

Article Structure: Detailed Sections

  • Title Page

    The title page must be prepared in English and include the following elements:

    1. Title: Your title should be brief, concise, and accurately descriptive of your work. Avoid using literature references, compound numbers, or non-standardized abbreviations within the title. It should be centered, typed in 14-point Times New Roman font, and boldface.
    2. Authors and Affiliations: Provide the full given names, middle initials, and family names for all authors for complete identification. These should be centered beneath the title, typed in 11-point Times New Roman, non-italic, and boldface. Use superscript lowercase letters to clearly indicate each author's affiliation. Affiliations should be as detailed as possible, including the department, faculty/college, university name, city with its zip code or P.O. Box, and country. The primary affiliation should reflect where the majority of the author's work was conducted. If an author has subsequently moved, their current address may be stated in addition to their primary affiliation, but please note that addresses will not be updated after the article's publication.
    3. Corresponding Author: The corresponding author should be clearly identified with an asterisk. Their contact details should be placed in a footnote. If available, the corresponding author's 16-digit ORCID should also be included.
    4. Authors and Affiliations: Provide the full given names, middle initials, and family names for all authors for complete identification. These should be centered beneath the title, typed in 11-point Times New Roman, non-italic, and boldface. Use superscript lowercase letters to clearly indicate each author's affiliation. Affiliations should be as detailed as possible, including the department, faculty/college, university name, city with its zip code or P.O. Box, and country. The primary affiliation should reflect where the majority of the author's work was conducted. If an author has subsequently moved, their current address may be stated in addition to their primary affiliation, but please note that addresses will not be updated after the article's publication.
    5. Corresponding Author: The corresponding author should be clearly identified with an asterisk. Their contact details should be placed in a footnote. If available, the corresponding author's 16-digit ORCID should also be included.

      A separate page within the same file must also contain the Title, Authors, and affiliations translated into Arabic, following the same order and formatting as above. Additionally, a short running title, with a maximum of 80 characters, should be provided.

  • Abstract

    The abstract should be a standalone summary, free of citations, and must not exceed 300 words. It should concisely outline the study's purpose, describe the methodology used, highlight the most important results, and present the main conclusions drawn from those results. Any nonstandard or uncommon abbreviations used must be defined at their first mention within the abstract. The abstract should be typed in 9-point Times New Roman, non-italic, and non-boldface.

  • Keywords

    Authors are required to provide relevant keywords, separated by semicolons. These keywords should be typed in 10-point Times New Roman, non-italic, and non-boldface.

  • Introduction

    This section should be succinct and presented without subheadings. Authors should clearly define the significance of their work and provide a justification for its publication. Any background discussion should be brief and focused strictly on pertinent material.

  • Material and Methods

    This section must contain sufficient detail to allow all procedures to be reproduced by others. It can be organized into subsections if multiple methods are described. Authors should strive for conciseness in experimental descriptions. The experimental section must include all information necessary to guarantee reproducibility. Previously published methods should be referenced, with only relevant modifications described in detail. All vendor information (company, city, and country) should be specified for chemicals, reagents, strains, and similar items. For statistical analysis, please state the appropriate test used, along with a hypothesized p-value or significance level.

  • Results and Discussion

    These two sections should be combined. The presentation of study results should be clear and concise. The use of tables and figures should be restricted to depicting data that is essential to the study's message and interpretation. Results should be presented in a logical sequence within the text, tables, and illustrations. The discussion component should explore the significance of the results, rather than merely repeating them. It should include the implications of the findings, their limitations, how the findings relate to other relevant work, and directions for future research.

  • Conclusion

    The main conclusion of the study should be presented in a short statement. This statement should highlight the study's goals and its importance. New hypotheses should be stated where warranted, and recommendations included when appropriate.

  • Acknowledgment

    All acknowledgments should be placed at the very end of the manuscript, preceding the references. This section should recognize individuals who contributed to the research or manuscript development but do not meet the criteria for authorship. Similarly, any organizations providing financial or other forms of support should also be acknowledged here.

  • Conflicts of Interest

    Authors are required to declare all relevant interests that could potentially be perceived as conflicting with the manuscript's publication. Authors should explain why each interest might represent a conflict. If no conflicts exist, authors must explicitly state this. The submitting author is responsible for ensuring that all co-authors declare their interests.

  • Funding

    Authors are required to describe all sources of funding that supported the work, including details of any grants received. If funds were received to cover publication costs, this should also be clearly stated. Please ensure that grant numbers and the standard spelling of funding agency names (which can be verified at https://search.crossref.org/funding) are used, as errors may affect future funding.

  • Author contribution

    Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; or have drafted the work or substantively revised it. Furthermore, each author must have approved the submitted version and agreed to be personally accountable for their own contributions, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated, resolved, and documented in the literature.

  • References

    Within the text, references should be indicated by Arabic numerals enclosed in square brackets, appearing in consecutive order throughout the text. For example. While authors can be referred to by name, the corresponding reference number must always be provided, IEEE references style should be applied.

Statements & Declarations

The following statements are mandatory and must be included in your submitted manuscript under the heading 'Statements and Declarations', placed immediately after the References section. Submissions that do not include the required statements will be returned as incomplete.

Funding

All sources of funding for the study should be disclosed. Clearly indicate any grants received in support of your research work and whether funds were received to cover publication costs. It's important to note that some funders may not refund article processing charges if the funder and grant number are not clearly and correctly identified in the paper. Funding information can be entered separately into the submission system by the authors during manuscript submission, and if available, will be deposited to FundRef if the manuscript is finally published.

Please include one of the following statements in this section:

  • “This research received no external funding.”
  • “This research was funded by [grant number].”
  • “The APC was funded by [funder name].”

Check carefully that the details given are accurate and use the standard spelling of funding agency names, which can be verified at https://search.crossref.org/funding, as any errors may affect your future funding.

Competing Interests

Authors must identify and declare any personal circumstances or interests that could be perceived as influencing the representation or interpretation of the reported research results. This includes financial or non-financial interests directly or indirectly related to the work, or those crucial to the study's outcome. Interests within the last three years of beginning the work should be reported, and interests outside this timeframe must be disclosed if they could reasonably be perceived as influencing the submitted work. The role of funding sponsors, if any, in the study's design, execution, analysis, interpretation, manuscript writing, or decision to publish the results must also be declared.

Example statements:

  • "The authors declare no conflict of interest."
  • "Financial interests: Author A and B declare they have no financial interests. Author C has received speaker and consultant honoraria from Company M. Dr. C has received speaker honorarium and research funding from Company M and Company N. Author D has received travel support from Company O. Non-financial interests: Author D has served on advisory boards for Company M and Company N."

Any role of the funding sponsors in the choice of research project; design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results must be declared in this section. If the sponsors had no such role, please state:

  • “The sponsors had no role in the design, execution, interpretation, or writing of the study.”

For more detailed information on completing this section, please refer to the journal's "Conflicts of Interest" policy under Editorial Policies.

Author Contributions Statement

Starting from 2026, authors are required to include a statement that specifies the individual contributions of every author to the research and preparation of the manuscript. Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software; or have drafted the work or substantively revised it; AND has approved the submitted version; AND agrees to be personally accountable for their own contributions and for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated, resolved, and documented in the literature.

Example statement (using CRediT taxonomy terms):

  • "All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [Author Initials] and [Author Initials]. The first draft of the manuscript was written by [Author Initials] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript."
  • For research articles with several authors, a more detailed paragraph specifying individual contributions using CRediT taxonomy terms is recommended (e.g., "Conceptualization, X.X. and Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing – Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.; Project Administration, X.X.; Funding Acquisition, Y.Y.").
  • For an explanation of CRediT terms, please refer to the CRediT taxonomy. For more background on CRediT, see here.

For more information, please read the section concerning "Authorship Principles" in the Editorial Policies.

Data Availability Statement

Starting from 2026, authors are required to provide a statement of data availability in their article. This statement should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. Data availability statements can also indicate whether data are available on request from the authors, or if no data are available.

Example statements:

  • "The datasets generated during and/or analyzed during the current study are available in the [repository name], [repository link]."
  • "The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request."
  • "No datasets were generated or analyzed during the current study."

For detailed information on data sharing expectations and guidelines, please refer to the journal's "Data Sharing Policy" section in the ">Editorial Policies page.

Research Data Policy and Data Availability Guidelines for Authors

The Mesopotamian Journal of Big Data encourages the sharing of research data to promote transparency, reproducibility, and the advancement of knowledge within the academic community. We recognize the importance of making data accessible to other researchers while respecting ethical and legal considerations. To this end, we have established the following guidelines for the inclusion of research data statements in submitted manuscripts:

Data Sharing Expectations:
Starting from 2026, authors are required to make their data available to the public whenever possible, except where privacy, confidentiality, or legal constraints apply. Data should be shared in a manner that allows verification of results and the reuse of data for further research.

Data Availability Statements:
Authors are required to include a Data Availability Statement in their manuscripts. This statement should clearly outline where the data supporting the findings of the study can be accessed, or explain why the data cannot be shared. Below are examples of acceptable Data Availability Statements:

  1. Data Available in a Public Repository:
    "The datasets generated during and/or analyzed during the current study are available in the [repository name], [repository link]."
  2. Data Available on Request:
    "The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request."
  3. No Data Available:
    "No datasets were generated or analyzed during the current study."

Ethics Approval (for studies involving humans or animals)

Authors of research involving human or animal subjects must include a statement confirming that the study was approved by the appropriate institutional and/or national research ethics committee. For research involving animals, their data, or biological material, authors should supply detailed information on the ethical treatment of their animals. If a study was granted exemption or did not require ethics approval, this should also be detailed.

Example statements:

  • "The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of [NAME OF INSTITUTE]."
  • "Ethical review and approval were waived for this study, due to [REASON]."

You may choose to exclude this statement if the study did not involve human or animal subjects.

Consent to Participate (for research involving human subjects)

For all research involving human subjects, freely-given, informed consent to participate in the study must be obtained from participants, and a statement to this effect should appear in the manuscript.

Example statements:

  • "Informed consent was obtained from all individual participants included in the study."
  • "Written informed consent was obtained from the parents [for minor participants]."

For additional help with completing this information, please refer to the "Informed Consent" section under Editorial Policies.

Informed Consent Statement

Any research article describing a study involving human subjects should contain this statement.

Please include one of the following statements regarding participation consent:

  • “Informed consent was obtained from all subjects involved in the study.”
  • “Patient consent was waived due to [REASON].”
  • “Not applicable.” (for studies not involving human subjects).

Additionally, if the manuscript includes data from identifiable patients, written informed consent for publication must be obtained from those participating patients. If applicable, please state:

  • “Written informed consent has been obtained from the patient to publish this paper.”

Consent to Publish (for individual person's data)

Individuals may consent to participate in a study but object to having their data published. If your manuscript contains any individual person’s data in any form (e.g., identifiable images, descriptions), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. This is particularly applicable to case studies. A statement confirming that consent to publish has been received from all participants should appear in the manuscript.

Example statements:

  • "The authors affirm that human research participants provided informed consent for publication of the images in Figure 1a, 1b and 1c."
  • "Written informed consent has been obtained from the patient to publish this paper."

For additional help with completing this information, please refer to the "Informed Consent" section under Editorial Policies.

Acknowledgments

In this section, you can acknowledge any support received that is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind.

Proofs

One set of page proofs will be sent via email to the corresponding author. Authors are requested to use these proofs solely for checking the typesetting, editing, completeness, and correctness of the text, tables, and figures. To ensure a quick and accurate publication, it is crucial that all corrections are returned in a single communication within 48 hours. Proofreading is the sole responsibility of the author. Please note that the publisher may proceed with the publication of an article if no response is received within the specified timeframe.

Revised Manuscripts

Authors are required to submit the revised version of their manuscripts within one month of receiving the editorial decision. It is important to understand that revision does not guarantee acceptance for publication, as amended submissions may be sent out for reevaluation.

When responding to reviewers' comments, authors must ensure that each comment is addressed individually, followed by their revision and/or response. If an author disagrees with a comment or suggestion, a clear justification for their stance must be provided. Any changes made in the manuscript should be highlighted (e.g., using "Track Changes" in Microsoft Word or by marking text as underlined or colored) to facilitate the re-evaluation process.

Authors should upload their revised submissions, including the following files:

  • Revised manuscript with changes highlighted: A version showing the changes made since the original submission, preferably using the "Track Changes" option in Microsoft Word. This should be uploaded as a "Revised Article with Changes Highlighted" file.
  • Response to reviewers: A document detailing the specific points made by each reviewer, including the authors' responses to all reviewers' and editors' comments, and a list of changes made to the manuscript. This should be uploaded as a "Response to reviewers" file.
  • Clean revised manuscript: A final, clean copy of the revised manuscript with author names, which does not show track changes or highlights. This should be uploaded as the "Manuscript" file.

After Acceptance

Upon acceptance of your article, it will be transferred to production for typesetting. Once the typesetting process is complete, you will receive the page proofs for your review, as outlined in the "Proofs" section above.

Peer Review

All manuscripts submitted to the Mesopotamian Journal of Big Data undergo a rigorous peer review process and are expected to meet high standards of academic excellence. If initially approved by the editor, submissions are then forwarded to peer reviewers. The Mesopotamian Journal of Big Data operates a double-blind review process, meaning that the identities of both the authors and the reviewers remain anonymous to each other throughout the review process. The ultimate decision regarding the acceptance or rejection of a manuscript rests with the editorial board, guided by the recommendations provided by the reviewers.

Our Research Integrity team may occasionally seek external advice beyond the standard peer review, particularly for submissions with significant ethical, security, biosecurity, or societal implications. In such cases, we may consult experts and the academic editor to determine appropriate actions, which could include engaging reviewers with specific expertise, additional assessment by other editors, or deciding against further consideration of the submission.

The full peer review process is detailed on the Editorial Policies page.

Supplementary Materials

Authors are welcome to publish online supplementary files alongside their articles or book chapters. Each supplementary file should include the article title, journal name, authors' names, affiliations, and the email address of the corresponding author. These supplementary files will be published as received from the authors, without any conversion, editing, or reformatting.

Article Publishing Charge

To cover open access costs, the journal charges an Article Processing Charge (APC). The APC is applicable only after a manuscript has successfully undergone peer review and is accepted for publication. Submission of articles is free of charge.

The standard article publishing charge for this journal is 1,000 USD. There is no submission charge.

At present, we do not offer waivers or discounts for Article Processing Charges.